M 519101
Alternative Names: M519101Latest Information Update: 03 Jun 2016
Price :
$50 *
At a glance
- Originator Maruho
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 02 Jun 2016 Discontinued - Phase-III for Pain (In adolescents, In children, In infants, In adults) in Japan (Topical)